Photo: infowars.com
"Novo Nordisk Exec Collapses Mid-Press Briefing with Trump on Drug Costs"
Novo Nordisk executive Gordon Findlay collapsed during a White House press briefing with Donald Trump, which focused on reducing medication costs, highlighting the high-stakes nature of pharmaceutical discussions.
- During a press briefing in the Oval Office on Thursday, Gordon Findlay of Novo Nordisk collapsed while standing next to Donald Trump, prompting immediate medical attention.
- The event was part of an announcement by Donald Trump aimed at addressing the rising costs of weight-loss medications, a significant issue affecting many Americans.
- Eli Lilly and Company CEO Dave Ricks was also present at the briefing, emphasizing the collaborative efforts among pharmaceutical leaders to tackle medication affordability.
Why It Matters
This incident underscores the intense pressures faced by pharmaceutical executives during high-profile events, while also emphasizing the urgent national conversation regarding medication costs and healthcare accessibility.